Renovia Inc. announced in August the closing of $42.3 million in financing, which consists of $10 million in venture debt and $32.2 million in Series B equity. The money will go on to fund clinic trials, future commercial launches, corporate development, and product development pipeline. Series B financing included participation from firms such as OSF Ventures,…